Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Schey

Showing results (11-20 of 68) with videos related to

Pageof 7
Sort By:
Clinical and Experimental Gastroenterology|June 20, 2015
Profile of rifaximin and its potential in the treatment of irritable bowel syndromeNatalya Iorio, Zubair Malik, Ron Schey
Gastroenterology|April 26, 2020
Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic DiseaseJonathan Gotfried, Timna Naftali, Ron Schey
Gastroenterology & Hepatology|October 1, 2011
Noncardiac chest pain: current treatmentRon Schey, Autumn Villarreal, Ronnie Fass
Cannabis and Cannabinoid Research|November 4, 2017
Review: The Role of Cannabinoids on Esophageal Function-What We Know Thus FarJonathan Gotfried, Rahul Kataria, Ron Schey
Digestive Diseases and Sciences|April 28, 2011
Lubiprostone for the treatment of adults with constipation and irritable bowel syndromeRon Schey, Satish S C Rao
Expert Review of Gastroenterology & Hepatology|July 26, 2011
The role of rifaximin therapy in patients with irritable bowel syndrome without constipationRon Schey, Satish S C Rao
Current Treatment Options in Gastroenterology|September 16, 2017
Diabetes and the Small IntestineJonathan Gotfried, Stephen Priest, Ron Schey
Expert Review of Gastroenterology & Hepatology|February 4, 2016
Emerging strategies for the treatment of gastroparesisJames Langworthy, Henry P Parkman, Ron Schey
The Israel Medical Association Journal : IMAJ|June 5, 2015
The epidemiology of eosinophilic esophagitis: an ongoing enigmaMahmoud Soubra, Yehudith Assouline-Dayan, Ron Schey
Current Treatment Options in Gastroenterology|November 9, 2018
The Role of Botulinum Toxin Injections for Esophageal Motility DisordersJessica L Sterling, Ron Schey, Zubair Malik
Pageof 7

Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Clinical and Experimental Gastroenterology|June 20, 2015
Profile of rifaximin and its potential in the treatment of irritable bowel syndromeNatalya Iorio, Zubair Malik, Ron Schey
Gastroenterology|April 26, 2020
Role of Cannabis and Its Derivatives in Gastrointestinal and Hepatic DiseaseJonathan Gotfried, Timna Naftali, Ron Schey
Gastroenterology & Hepatology|October 1, 2011
Noncardiac chest pain: current treatmentRon Schey, Autumn Villarreal, Ronnie Fass
Cannabis and Cannabinoid Research|November 4, 2017
Review: The Role of Cannabinoids on Esophageal Function-What We Know Thus FarJonathan Gotfried, Rahul Kataria, Ron Schey
Digestive Diseases and Sciences|April 28, 2011
Lubiprostone for the treatment of adults with constipation and irritable bowel syndromeRon Schey, Satish S C Rao
Expert Review of Gastroenterology & Hepatology|July 26, 2011
The role of rifaximin therapy in patients with irritable bowel syndrome without constipationRon Schey, Satish S C Rao
Current Treatment Options in Gastroenterology|September 16, 2017
Diabetes and the Small IntestineJonathan Gotfried, Stephen Priest, Ron Schey
Expert Review of Gastroenterology & Hepatology|February 4, 2016
Emerging strategies for the treatment of gastroparesisJames Langworthy, Henry P Parkman, Ron Schey
The Israel Medical Association Journal : IMAJ|June 5, 2015
The epidemiology of eosinophilic esophagitis: an ongoing enigmaMahmoud Soubra, Yehudith Assouline-Dayan, Ron Schey
Current Treatment Options in Gastroenterology|November 9, 2018
The Role of Botulinum Toxin Injections for Esophageal Motility DisordersJessica L Sterling, Ron Schey, Zubair Malik
Pageof 7